ID   HPC-Y19
AC   CVCL_6916
DR   cancercelllines; CVCL_6916
DR   Cosmic; 730522
DR   Wikidata; Q54890256
RX   PubMed=2208167;
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=2208167).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Unspecified (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=2208167;
RA   Yamaguchi N., Yamamura Y., Koyama K., Ohtsuji E., Imanishi J.,
RA   Ashihara T.;
RT   "Characterization of new human pancreatic cancer cell lines which
RT   propagate in a protein-free chemically defined medium.";
RL   Cancer Res. 50:7008-7014(1990).
//
RX   PubMed=7961102; DOI=10.1111/j.1349-7006.1994.tb02898.x; PMCID=PMC5919355;
RA   Suwa H., Yoshimura T., Yamaguchi N., Kanehira K., Manabe T.,
RA   Imamura M., Hiai H., Fukumoto M.;
RT   "K-ras and p53 alterations in genomic DNA and transcripts of human
RT   pancreatic adenocarcinoma cell lines.";
RL   Jpn. J. Cancer Res. 85:1005-1014(1994).
//